Labuxtinib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H16FN5O2
Molecular Weight	377.3717
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC=C(C=C1NC(=O)C2=CN=C3C=CC=CN23)C4=NOC(=N4)[C@H]5C[C@@H]5F

InChI

InChIKey=RHNJOZCVGSBEAG-KBPBESRZSA-N

InChI=1S/C20H16FN5O2/c1-11-5-6-12(18-24-20(28-25-18)13-9-14(13)21)8-15(11)23-19(27)16-10-22-17-4-2-3-7-26(16)17/h2-8,10,13-14H,9H2,1H3,(H,23,27)/t13-,14-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C20H16FN5O2
Molecular Weight	377.3717
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 20:18:29 UTC 2023` Edited by `admin` on `Sat Dec 16 20:18:29 UTC 2023`
Record UNII	QNX4G754W6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Labuxtinib

Official Name

English

Imidazo[1,2-a]pyridine-3-carboxamide, N-[5-[5-[(1R,2S)-2-fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]-

Systematic Name

English

N-[5-[5-[(1R,2S)-2-Fluorocyclopropyl]-1,2,4-oxadiazol-3-yl]-2-methylphenyl]imidazo[1,2-a]pyridine-3-carboxamide

Systematic Name

English

labuxtinib [INN]

Common Name

English

Code System Code Type Description

CAS

1426449-01-5

Created by admin on Sat Dec 16 20:18:29 UTC 2023 , Edited by admin on Sat Dec 16 20:18:29 UTC 2023

PRIMARY

PUBCHEM

71280305

Created by admin on Sat Dec 16 20:18:29 UTC 2023 , Edited by admin on Sat Dec 16 20:18:29 UTC 2023

PRIMARY

FDA UNII

QNX4G754W6

Created by admin on Sat Dec 16 20:18:29 UTC 2023 , Edited by admin on Sat Dec 16 20:18:29 UTC 2023

PRIMARY

INN

12711

Created by admin on Sat Dec 16 20:18:29 UTC 2023 , Edited by admin on Sat Dec 16 20:18:29 UTC 2023

PRIMARY

Related Record Type Details


					QNX4G754W6

Labuxtinib

ACTIVE MOIETY

Comments:

tyrosine kinase inhibitor

Amount: